| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.15▼ | 2.13▲ | 2.13▲ | 2.41▼ | 2.47▼ |
| MA10 | 2.14▲ | 2.12▲ | 2.16▼ | 2.53▼ | 2.18▼ |
| MA20 | 2.12▲ | 2.16▼ | 2.24▼ | 2.52▼ | 2.02▲ |
| MA50 | 2.12▲ | 2.35▼ | 2.49▼ | 2.18▼ | 1.77▲ |
| MA100 | 2.14▲ | 2.50▼ | 2.56▼ | 1.98▲ | 1.69▲ |
| MA200 | 2.23▼ | 2.54▼ | 2.31▼ | 1.75▲ | 3.13▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.013▲ | 0.002▲ | -0.075▼ | 0.038▲ |
| RSI | 56.802▲ | 44.509▼ | 40.109▼ | 40.970▼ | 53.647▲ |
| STOCH | 78.137 | 63.293 | 39.567 | 57.255 | 70.026 |
| WILL %R | -40.000 | -49.123 | -74.107 | -62.759 | -62.759 |
| CCI | 148.600▲ | 79.896 | -39.648 | -207.979▼ | 65.493 |
|
Monday, December 15, 2025 05:30 AM
Milestone Pharmaceuticals (NASDAQ:MIST) shares jumped roughly 35% after the U.S. Food and Drug Administration approved CARDAMYST, the first nasal spray that patients can self-administer to treat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/12/25 | 2.205 | 2.205 | 2.00 | 2.15 | 12,739,500 |
| 16/12/25 | 2.34 | 2.57 | 2.20 | 2.20 | 13,622,170 |
| 15/12/25 | 2.905 | 2.915 | 2.10 | 2.345 | 71,782,781 |
| 12/12/25 | 3.06 | 3.06 | 1.61 | 2.41 | 27,773,530 |
| 11/12/25 | 2.63 | 2.965 | 2.604 | 2.95 | 7,484,500 |
| 10/12/25 | 2.61 | 2.67 | 2.55 | 2.67 | 3,217,900 |
| 09/12/25 | 2.66 | 2.676 | 2.50 | 2.63 | 4,308,600 |
| 08/12/25 | 2.71 | 2.728 | 2.57 | 2.66 | 4,575,700 |
| 05/12/25 | 2.67 | 2.72 | 2.565 | 2.68 | 3,455,100 |
| 04/12/25 | 2.65 | 2.66 | 2.575 | 2.64 | 3,488,000 |
|
|
||||
|
|
||||
|
|